The first-class neurology practice is located in Durham, North Carolina, and the Duke University neurology department offers both a clinical and an academic approach to medical and surgical neurology.
Duke neurologist Dr. Daniel Kuklinski is a clinical director and an assistant professor in the Duke Neurology Department.
The department offers a variety of elective programs including: Neurology, Neuropsychiatry, Cardiology, and Endocrinology.
In addition to the clinic, Duke neurologists also provide research and clinical services for other academic institutions, including the University of North Carolina at Chapel Hill and the University at Buffalo.
This summer, Duke will hold a joint clinical and academic neuroscience symposium on neurology and cardiovascular disease with the University Health Network in Raleigh, North Carolinians will have the opportunity to explore elective courses in electrophysiology, neuroscience, and cardiovascular medicine.
The Duke Neurologists have partnered with the university’s Center for Neurosurgery and the Center for Brain Injury Prevention, which is the largest academic medical center for stroke and trauma neurology in the U.S. Dr. Kukluinski said, “I believe the collaboration with the NCBI enables us to be a leader in neurology research, which, in turn, will lead to a better understanding of neurological and neuropsychiatric diseases and their prognosis.”
Duke neurologists have collaborated on several studies on the effects of radiation therapy on brain function.
In 2016, Dr. James E. Hamer, Duke University School of Medicine’s director of neurosurgery, led the first large-scale study of the effect of low-level radiation on the brains of people with spinal cord injuries.
His research revealed that a single, very low dose of radiation significantly reduced the risk of developing stroke and traumatic brain injury in people with cerebral palsy.
Dr Hamer also noted that there are many other mechanisms by which low-dose radiation can decrease the risk for neurodegenerative diseases.
Dr. Hama has been a co-author of numerous scientific papers published in peer-reviewed journals.
He is also a coauthor of the NIH-funded Neurology and Neuropsychology Symposium paper.
He said, “[The] neurosurgeons at Duke have done an outstanding job in the field, and I look forward to continuing to work with them and their colleagues.”
Dr. Homa said that Duke’s neurosurgeon department is currently working on a new publication on the neurodegeners of brain injury.
“We’re hoping to publish the results of our study in late fall or early spring,” Dr. Dray said.
Dr Hama noted that Duke has an extensive list of other research partners and a strong network of doctors that can provide expertise in a wide variety of areas of neurological pathology.
“If you look at the neurology programs across the country, there’s a significant gap between what the community knows about neurodegenative diseases and what neurologists are doing,” he said.